Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1
Study sponsorship, authorizations and ethics This study was an investigator initiated trial sponsored by Gustave Roussy and covered…
20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs
Collection of sandflies, which can transmit river blindness Universal Images Group via Getty Images Occasionally I’ll go watch…
New longevity drug SRN-901 shows 33% lifespan boost
Oral combination therapy boosts lifespan 33% and slows frailty, pointing to a more holistic approach to aging. What…
2 AI Healthcare Stocks to Buy Right Now
While the advent of artificial intelligence (AI) has obviously changed the world, not every utilization of AI has…
SuppCo launches certification to verify actives in dietary supplements
The new program complements SuppCo’s TrustScore supplement quality rating system and builds on earlier testing initiatives, which revealed…
Marty Makary addresses staff concerns over drug voucher program
WASHINGTON — At an employee town hall on Tuesday, Food and Drug Administration leaders tried to quell staff…
Pharma’s ‘Dr. Optimistic’ is worried about the industry’s future
In July 2006, The New York Times sent young reporter Alex Berenson to Pfizer to interview me about…
FDA reviewers didn’t get to vote on first priority voucher drug
WASHINGTON — The Food and Drug Administration has promised companies that earn a Commissioner’s National Priority Voucher a one-…
New FDA priority review vouchers go to Lilly, Novo, Vertex
WASHINGTON — The Food and Drug Administration on Thursday announced the second batch of companies being granted a “Commissioner’s…
Synthetic lethality in cancer drug discovery: challenges and opportunities
Hartwell, L. H., Szankasi, P., Roberts, C. J., Murray, A. W. & Friend, S. H. Integrating genetic approaches…